Pharmaceutical companies must contend with challenges from supply chain lapses (theft, diversion, S.O.P. deviations, product recalls, reverse logistics etc.) counterfeiting and stringent regulations. These challenges get compounded when dealing across the states and country business operations, besides that not only impact tangible profits but also the intangible brand credibility. In this context, there is also a credible increase in public awareness about the genuineness of medicine (in particular medicine that require cold chain) and their predictability of clinical outcomes. Providing visibility and full traceability becomes a paramount importance to both the Industry and the Govt. – A fool proof solution not only brings transparency in the system, but can also be a key differentiator, and undoubtedly can create immense opportunities for a competitive advantage.

In a bold move to strengthen its hepatology pipeline,...

Pharmaceutical & medical devices Industry is fast adapting to these changes at various levels of the value chain. Billions of dollars are being spent on digital transformation projects ranging from usage of AI & ML in product development, production and predictive maintenance, Blockchain in supply chain and data management & analytics in strategic decision making. This article focuses on Omnichannel marketing, one of the key digital transformations that the industry is learning and implementing at a rapid pace. Omnichannel Marketing: Promise and Possibilities An industry that historically focused all their brand building and market shaping efforts through F2F meetings & medical education programs has started making giant strides in multi-channel strategy now. A digital journey that started with an e-detailing platform has progressed fast by adding brand websites, Approved E-Mails, social media, webinars and other media effectively creating a multi-channel strategy. The only hindside to this is, all these channels work independently, expecting HCPs to find and sort out information themselves.

For more than fifty years, the MRI industry treated...

“We are getting too happy, for too little”: these...

Here is an analytical blog comparing the IQVIA MFR...

The latest PharmaTrac report for December 2025 offers a...

Zydus’ ZYCUBO May Be the Proof Point the Industry...

For more than fifty years, the MRI industry treated...

The Telangana Drugs Control Administration’s stop-use notice on a...

Here is an analytical blog comparing the IQVIA MFR...

The latest PharmaTrac report for December 2025 offers a...

Zydus’ ZYCUBO May Be the Proof Point the Industry...

For more than fifty years, the MRI industry treated...

The Telangana Drugs Control Administration’s stop-use notice on a...

Here is an analytical blog comparing the IQVIA MFR...

The latest PharmaTrac report for December 2025 offers a...

Zydus’ ZYCUBO May Be the Proof Point the Industry...

For more than fifty years, the MRI industry treated...

The Telangana Drugs Control Administration’s stop-use notice on a...

Here is an analytical blog comparing the IQVIA MFR...

The latest PharmaTrac report for December 2025 offers a...

Zydus’ ZYCUBO May Be the Proof Point the Industry...

For more than fifty years, the MRI industry treated...

The Telangana Drugs Control Administration’s stop-use notice on a...